Haiou H Yao

Title: Innovations by Haiou H Yao in Glycated Hemoglobin Assays

Introduction

Haiou H Yao is an accomplished inventor based in Libertyville, IL (US). He has made significant contributions to the field of medical diagnostics, particularly in the measurement of glycated hemoglobin. With a total of 2 patents, his work has the potential to enhance diabetes management and patient care.

Latest Patents

One of Haiou H Yao's notable patents involves a glycated hemoglobin assay that utilizes a straightforward procedure for determining standardized %GHb in whole blood samples. This method is correlated to the Diabetes Control and Complications Trial (DCCT). The process begins with incubating a lysed whole blood sample with a solid phase coupled with boronic acid or a similar boronate compound through known covalent linkage chemistries. Following this, a labeled antibody to human hemoglobin is added, and the resulting signal is directly proportional to the %GHb in the sample. The advantages of this assay include high precision and the ability to automate the process, allowing for high throughput. This innovation also consolidates testing, eliminating the need for separate measurements of GHb and total hemoglobin (THb).

Career Highlights

Haiou H Yao is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has focused on developing advanced diagnostic tools that improve the accuracy and efficiency of blood testing.

Collaborations

Throughout his career, Haiou H Yao has collaborated with esteemed colleagues, including Evelyn Mok Lee and David A Westerberg. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.

Conclusion

Haiou H Yao's innovative work in glycated hemoglobin assays represents a significant advancement in diabetes diagnostics. His contributions are poised to improve patient outcomes and streamline testing processes in clinical settings.